Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siriporn Chattipakorn

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|April 14, 2005
Electrophysiological concept of ventricular defibrillation mechanismSiriporn Chattipakorn, Nipon Chattipakorn
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 5, 2011
Effects of cilostazol in the heartNatnicha Kanlop, Siriporn Chattipakorn, Nipon Chattipakorn
The Canadian Journal of Cardiology|April 5, 2011
Roles of mitochondrial benzodiazepine receptor in the heartSirirat Surinkaew, Siriporn Chattipakorn, Nipon Chattipakorn
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 1, 2011
Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injuryPunate Weerateerangkul, Siriporn Chattipakorn, Nipon Chattipakorn
Diabetes & Vascular Disease Research|April 13, 2012
Cardioprotective effects of incretin during ischaemia-reperfusionKroekkiat Chinda, Siriporn Chattipakorn, Nipon Chattipakorn
Metabolic Brain Disease|February 24, 2015
Testosterone deficiency, insulin-resistant obesity and cognitive functionHiranya Pintana, Nipon Chattipakorn, Siriporn Chattipakorn
Indian Pacing and Electrophysiology Journal|September 1, 2006
Electrophysiological mechanisms of ventricular fibrillation inductionNipon Chattipakorn, Kirkwit Shinlapawittayatorn, Siriporn Chattipakorn
Current Pharmaceutical Design|March 2, 2013
Roles of p38-MAPK in insulin resistant heart: evidence from bench to future bedside applicationSarawut Kumphune, Siriporn Chattipakorn, Nipon Chattipakorn
European Journal of Clinical Pharmacology|December 30, 2011
Role of p38 inhibition in cardiac ischemia/reperfusion injurySarawut Kumphune, Siriporn Chattipakorn, Nipon Chattipakorn
World Journal of Cardiology|June 14, 2011
PPARγ activator, rosiglitazone: Is it beneficial or harmful to the cardiovascular system?Siripong Palee, Siriporn Chattipakorn, Arintaya Phrommintikul, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet|April 14, 2005
Electrophysiological concept of ventricular defibrillation mechanismSiriporn Chattipakorn, Nipon Chattipakorn
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 5, 2011
Effects of cilostazol in the heartNatnicha Kanlop, Siriporn Chattipakorn, Nipon Chattipakorn
The Canadian Journal of Cardiology|April 5, 2011
Roles of mitochondrial benzodiazepine receptor in the heartSirirat Surinkaew, Siriporn Chattipakorn, Nipon Chattipakorn
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 1, 2011
Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injuryPunate Weerateerangkul, Siriporn Chattipakorn, Nipon Chattipakorn
Diabetes & Vascular Disease Research|April 13, 2012
Cardioprotective effects of incretin during ischaemia-reperfusionKroekkiat Chinda, Siriporn Chattipakorn, Nipon Chattipakorn
Metabolic Brain Disease|February 24, 2015
Testosterone deficiency, insulin-resistant obesity and cognitive functionHiranya Pintana, Nipon Chattipakorn, Siriporn Chattipakorn
Indian Pacing and Electrophysiology Journal|September 1, 2006
Electrophysiological mechanisms of ventricular fibrillation inductionNipon Chattipakorn, Kirkwit Shinlapawittayatorn, Siriporn Chattipakorn
Current Pharmaceutical Design|March 2, 2013
Roles of p38-MAPK in insulin resistant heart: evidence from bench to future bedside applicationSarawut Kumphune, Siriporn Chattipakorn, Nipon Chattipakorn
European Journal of Clinical Pharmacology|December 30, 2011
Role of p38 inhibition in cardiac ischemia/reperfusion injurySarawut Kumphune, Siriporn Chattipakorn, Nipon Chattipakorn
World Journal of Cardiology|June 14, 2011
PPARγ activator, rosiglitazone: Is it beneficial or harmful to the cardiovascular system?Siripong Palee, Siriporn Chattipakorn, Arintaya Phrommintikul, et al.
Pageof 8